VirTra’s $24.9 million backlog, differentiated simulator technology, and expanding defense access create asymmetric turnaround upside, but grant-dependent demand, operating losses, and control weaknesses make execution and liquidity the decisive tests.
Overview
VirTra, Inc. (NASDAQ: VTSI) develops simulator-based firearms, judgmental use-of-force, and de-escalation training systems for law enforcement and defense. It sells multi-screen equipment and accessories, service agreements, and software/subscription offerings, including STEP, which can convert capital purchases into recurring operating expenses. Its V-300 300-degree system, certified content, proprietary recoil technology, and stress-induction hardware differentiate it from traditional ranges and headset-based alternatives. **The near-term recovery case rests on converting a $24.9 million backlog as delayed grants, customer approvals, and site readiness improve.** Q2 FY2026 revenue was $5.76 million, down 17.4% year over year but up 66.0% sequentially and 63.8% above consensus; EPS was -$0.02 versus -$0.11 expected. Gross margin fell to 59.0% from 69.0%, and TTM revenue of $17.5 million coincided with a -15.8% net margin. At $2.73, shares trade at approximately 1.8x TTM sales, 1.5x EV/sales, and 0.7x book value. The report’s probability-weighted five-year target is $7.57, supported by potential STEP adoption, Army Marketplace contracts, international sales, and a CBP award of up to $14 million; material control weaknesses and cash burn remain key constraints.